
pmid: 28714995
handle: 11577/3266425
Male, Anticholesteremic Agents, Injections, Subcutaneous, Antibodies, Monoclonal, Cholesterol, LDL, Coronary Artery Disease, Middle Aged, Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Proprotein Convertase 9; Treatment Outcome, Antibodies, Monoclonal, Humanized, Treatment Outcome, Double-Blind Method, Humans, Female, Proprotein Convertase 9, Follow-Up Studies
Male, Anticholesteremic Agents, Injections, Subcutaneous, Antibodies, Monoclonal, Cholesterol, LDL, Coronary Artery Disease, Middle Aged, Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Proprotein Convertase 9; Treatment Outcome, Antibodies, Monoclonal, Humanized, Treatment Outcome, Double-Blind Method, Humans, Female, Proprotein Convertase 9, Follow-Up Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
